← Back to headlines
Royalty Pharma plc Shows Resilience with 25.6% Gain in Q1
Royalty Pharma plc (RPRX) demonstrated resilience in the first quarter, achieving a significant gain of 25.6% in its performance.
13 Apr, 13:23 — 13 Apr, 13:23
Sources
Showing 1 of 1 sources
